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Abstract
Background: Burkholderia pseudomallei (Bp) is a category B biothreat organism that causes a
potentially fatal disease in humans and animals, namely melioidosis. Burkholderia thailandensis (Bt) is
another naturally occurring species that is very closely related to Bp. However, despite this closely
related genotype, Bt is considered avirulent as it does not cause the disease. In the present study,
we compared the growth kinetics of B. pseudomallei strain 844 (Bp-844) in human monocyte-
derived dendritic cells (MoDCs) and macrophages (Mφs), as well as its ability to stimulate host cell
responses with those of B. thailandensis strain UE5 (Bt-UE5).
Results: Primary human MoDCs and Mφs were infected with Bp-844 and its intracellular growth
kinetics and ability to induce host cell responses were evaluated. The results were compared with
those obtained using the Bt-UE5. In human MoDCs, both bacteria were similar in respect to their
ability to survive and replicate intracellularly, induce upregulation of costimulatory molecules and
cytokines and bias T helper cell differentiation toward a Th1 phenotype. By contrast, the two
bacteria exhibited different growth kinetics in human Mφs, where the intracellular growth of Bt-
UE5, but not Bp-844, was significantly suppressed. Moreover, the ability of Mφs to kill Bp-844 was
markedly enhanced following stimulation with IFN-γ.
Conclusion: The data presented showed that while both strains were similar in their ability to
survive and replicate in human MoDCs, only Bp-844 could readily replicate in human Mφs. Both
bacteria induced similar host cellular responses, particularly with regard to their ability to bias T
cell differentiation toward a Th1 phenotype.
Background
Melioidosis is a serious infectious disease caused by Bur-
kholderia pseudomallei (Bp), a gram-negative bacterium
that is classified as a category B bioterrorism agent by
Centers for Disease Control and Prevention [1]. It is found
in soil and water and is endemic in the region between
20°N and 20°S of the equator including Southeast Asian
countries and northern Australia [2]. This soil-saprophyte
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readily in murine phagocytic and non-phagocytic cell
lines [3]. It is the causative agent of the potentially fatal
disease, meloidiosis, which occurs in both humans and
animals. Human melioidosis has a broad clinical spec-
trum ranging from a seropositive subclinical condition to
an acute fatal septicemia [2].
B. thailandensis (Bt) is a non-pathogenic environmental
saprophyte that was formerly considered to be an aviru-
lent biotype of Bp [4]. It is genetically and phenotypically
very similar to Bp but is markedly less virulent in both
human and animal models. For example, Bp is at least
106-fold more virulent than Bt in BALB/c mice and so far
none of the 1,200 clinical isolates reported have displayed
the Bt phenotype [4]. Bt is usually present together with
Bp in the regions where melioidosis is endemic, e.g.,
northeast Thailand [5]. In order to further delineate the
pathogenesis mechanism(s) of Bp in humans, which
remain largely unresolved, the in vitro interactions of Bp
strain 844 and Bt strain UE5 with primary human phago-
cytic cells were compared. We previously showed that Bp
adhered to and invaded a human epithelial cell line more
efficiently than Bt [6]. In the present study, we continued
this line of study by comparing the intracellular survival
and growth kinetics of Bp-844 and Bt-UE5 in primary
human monocyte-derived dendritic cells (MoDCs) and
human macrophages (Mφs) and the respective host cell
responses with regard to costimulatory molecule expres-
sion, cytokine production and MoDC-driven allogeneic T
cell differentiation.
Results
Intracellular survival and replication of Bp-844 and Bt-
UE5 in human MoDCs and Mφs
In order to study the intracellular survival and growth
kinetics of both Burkholderia strains, primary human
MoDCs and Mφs, cells were infected with Bp-844 and Bt-
UE5 at a multiplicity of infection (MOI) of 1 and the
number of viable intracellular bacteria was determined at
3, 8, 12 and 16 hr after infection (Figure 1A and 1B).
Given the protocol used, the earliest time point where the
number of intracellular bacteria could be determined was
3 hours post infection (T3). At this initial stage of infec-
tion, the mean level of intracellular Bp-844 in the MoDCs
was higher than that in Bt-UE5 (Figure 1B), although the
difference was not statistically significant (P = 0.106). As
the infection progressed, the intracellular numbers of
both bacteria, as measured at T8, declined compared with
the 3-hr time point. At later time points (T12 and T16),
however, both Bp-844 and Bt-UE5 multiplied exponen-
tially inside MoDCs and exhibited similar kinetics until
the experiment was terminated (T16), thus resulting in
similar numbers of intracellular bacteria 16 hr after infec-
tion.
The results in Mφs were markedly different in that intrac-
ellular growth of Bp-844 was much better than that of Bt-
UE5. While the numbers of intracellular bacteria were
similar for both organisms in the early stages of growth
(Figure 1A, T3 and T8), the number of intracellular Bp-844
was significantly higher at T16 (P < 0.01, paired-samples t-
test). In fact, the growth of Bt-UE5 was completely halted
between T12 and T16. The difference was more clear when
comparing the intracellular growth rates of the two organ-
isms in Mφs. Bp-844 grew with a doubling time of 3 hr 2
min in Mφs (T8 to T16) while that for Bt-UE5 could not be
determined as the level of intracellular Bt-UE5 was rela-
tively low and remained at the same level throughout the
observation period. Moreover, the replication rate of both
Bp-844 and Bt-UE5 during the exponential growth phase
(T8 to T16) was higher inside MoDCs (1 hr 36 min) than
that of Bp-844 in Mφs (3 hr 2 min). It should be men-
tioned that the intracellular growth rates of both organ-
isms in both primary phagocytic cell cultures were
considerably lower than those in the cell-free culture
medium (40 min for Bp-844 and 37 min for Bt-UE5). In
conclusion, whereas both Burkholderia stains survived and
replicated equally well in MoDCs, the intracellular growth
of Bt-UE5, but not Bp-844, was significantly suppressed in
Mφs.
Pre-activation of Mφs with recombinant human IFN-γ for
16 hr prior to infection resulted in a reduction in the intra-
cellular survival of Bp-844 in a dose-dependent manner,
as judged from the number of intracellular bacteria deter-
mined 16 hr after the infection was started (Figure 1C).
Although the intracellular survival was only significantly
reduced when the IFN-γ was added to the Mφs at final con-
centration of 2000 U/ml (P < 0.01, paired-samples t-test),
some reduction in survival, relative to the untreated con-
trol, could still be observed with IFN-γ pre-treatment at
concentrations as low as 20 U/ml (Figure 1C). In MoDCs
pre-treated with 2000 U/ml IFN-γ, a significant reduction
(P = 0.049, paired-samples t-test, Figure 1D) in the intrac-
ellular level of Bp-844 was also observed, but the level of
reduction was less than that noted in Mφs (Figure 1C). The
effect of IFN-γ on bacterial survival was not the result of
reduced bacterial uptake since both IFN-γ-treated and
untreated cells displayed similar numbers of intracellular
bacteria at the 3 hr post-infection time point (data not
shown). Thus, this set of experiments showed that IFN-γ
could stimulate Mφs, and to a lesser extent MoDCs, to
acquire enhanced antibacterial killing capacity to reduce
the intracellular survival and growth of Bp-844.
Upregulation of costimulatory molecules, surface markers 
and cytokine production in Bp-844- and Bt-UE5-infected 
cells
Given the different fates on intracellular bacterial survival
profiles noted above, it was of interest to examine thePage 2 of 8
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timulatory molecules, surface markers and cytokines.
Exposure of MoDCs to Bp-844 and Bt-UE5at a MOI of 1
for 24 hr readily induced cell maturation as judged by sig-
nificant increases in the levels of the maturation marker,
CD83 (Figure 2B). Under the same conditions, both Bp-
844 and Bt-UE5 induced upregulation of the costimula-
tory molecule, CD86, in MoDCs and Mφs (Figure 2A and
2B). The effect of bacterial infection on the upregulation
of other costimulatory molecules varied. For example,
while the levels of CD40 (Figure 2B) and CD80 (data not
shown) in MoDCs also increased, it was rather surprising
to observe that infection of Mφs with either Bp-844 or Bt-
UE5 actually caused a reduction in the levels of CD80 and
CD11b (Figure 2A). The reduction noted with the Mφs is
unlikely to be related to a technical artifact because when
compared with the background MFI (mean fluorescence
intensity) obtained with PBS, Escherichia coli LPS also
slightly depressed CD11b expression, a finding that is
consistent with earlier reports by other investigators using
some other human Mφmodels [7,8].
Infection with either Bp-844 or Bp-UE5 stimulated similar
degrees of cytokine secretion in MoDCs and Mφs. Signifi-
cant elevations in the levels of IL-10 and TNF-α (P < 0.05,
paired-samples t-test) were found in the supernatant fluid
of the Mφcultures infected with either Bp-844 or Bt-UE5
(Figure 2C). Infection with either organism also stimu-
Survival profiles of Bp-844 and Bt-UE5 in Mφs and MoDCsFigure 1
Survival profiles of Bp-844 and Bt-UE5 in Mφs and MoDCs. Immature (A and B) and IFN-γ activated (C and D) cells 
were exposed to Bp-844 and Bt-UE5 at a MOI of 1 and the mean numbers of intracellular bacteria determined up to 16 hr 
post-infection are shown. The error bars for each data point represent the standard error from the mean. Number in paren-
thesis indicates the number of donors in each experiment. * indicates a significant difference as analyzed with paired-samples t-
test, with P < 0.01.Page 3 of 8
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samples t-test) in the MoDC cultures (Figure 2D). The
level of IL-12p70 and not the TNF-α was determined in
the MoDC supernatants because it is more readily related
to the polarization of naïve T cells to Th1 phenotype [9].
The proportion of pro-inflammatory to anti-inflamma-
tory cytokines induced by these 2 bacteria was calculated
and found to be not different from one another (data not
shown). It should be mentioned that the changes in the
levels of costimulatory molecules and the increased secre-
tion of cytokines induced by these 2 bacteria did not
depend on their invasive properties or the numbers of
bacteria internalized as exposure to organisms that had
been killed by PFA treatment induced changes in cytokine
and costimulatory molecule levels that were similar to
those observed using living bacteria (data not shown). In
summary, Bp-844 and Bt-UE5 appeared to exert roughly
similar influences on the cellular responses of MoDCs and
Mφs, judging from the expression levels of costimulatory
molecules and cytokine production.
Host cell responses upon Bp-844 and Bt-UE5 infectionFigure 2
Host cell responses upon Bp-844 and Bt-UE5 infection. Mφs (A and C) and MoDCs (B and D) were infected with Bp-
844 or Bt-UE5 at MOI of 1 for 24 hr and 250 μg/ml kanamycin was added 2 hr after infection. Expression levels of CD86, CD80 
and CD11b of Mφs (A) and CD86, CD83 and CD40 of MoDCs (B) on the cell surface were determined with flow cytometry 
and the results are shown as mean and SEM. Cytokines in supernatants of infected Mφs (C) and infected MoDCs (D) were 
measured by ELISA and results are shown as mean and SEM, with each symbol representing the level from individual donor. E. 
coli LPS (1 μg/ml) and PBS were used as controls. Number in parenthesis indicates the number of donors for each experiment. 
MFI = mean fluorescence intensity.Page 4 of 8
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and Bt-UE5-stimulated MoDCs
We compared the ability of Bp-844-and Bt-UE5-stimu-
lated MoDCs to induce Th1-Th2 differentiation. A MoDC-
allogeneic naïve CD4+ co-culture system was employed
essentially as described earlier by Bergman et al. (9).
MoDCs from 5 different donors that had been exposed to
PFA-fixed Bp-844 or Bt-UE5 were incubated with alloge-
neic T cells and the extent of T-cell polarization was deter-
mined (Figure 3A). Scatter plots of flow cytometry
analyses from one representative MoDC donor are sepa-
rately shown in Figure 3B. The results with all 5 donors
showed that MoDCs exposed to either of the PFA-fixed
bacteria biased toward a Th1 polarization, based on the
observation that the majority of T cells in samples that
had been exposed to the bacteria produced intracellular
IFN-γ which is a characteristic of Th1 cells. In conclusion,
stimulation of MoDCs with either Bp-844 or Bt-UE5
induced indistinguishable T-helper cell profiles, i.e., both
predominantly induced naïve T cells to differentiate to a
Th1 cell population.
Discussion
Different lines of evidence from patients with melioidosis,
including the elevation of pro- and anti-inflammatory
cytokines in serum, suggest the importance of innate
immunity in determining the outcome of infection [2,10].
There is also evidence in humans showing that recovery
from melioidosis may depend, in part, on cell-mediated
arm of adaptive immune system [11]. The latter is par-
tially dependent on the type of Th cell differentiation
which is controlled in part by activated DCs. Studies of
experimentally induced melioidosis in different inbred
strains of animals have shown the importance of genetic
background in determining the course of the infection
[12]. Despite numerous studies in animal melioidosis
models using mutant and wild type bacteria [13,14] a
complete understanding of the mechanisms involved in
pathogenesis, particularly in humans, has yet to be real-
ized. We felt that additional approaches looking at the
effects of infection on isolated human phagocytic cell
populations would contribute new insights into the path-
ogenic mechanism of the disease. We also reasoned that
using virulent Bp as well as its genetically related avirulent
natural counterpart, Bt, might highlight aspects of the
host response that play a role in virulence and pathogen-
esis. Moreover, the use of primary human cells, instead of
animal cells or cell lines, would yield results that are more
relevant in regard to the human disease. We had previ-
ously demonstrated that this same Bp strain adhered to
T helper cell differentiation profiles driven by Bp-844- or Bt-UE5-stimulated MoDCsFigur  3
T helper cell differentiation profiles driven by Bp-844- or Bt-UE5-stimulated MoDCs. MoDCs were allowed to 
mature after priming with PFA-fixed Bp-844 or Bt-UE5 for 24 hr. These matured MoDCs were then co-cultured with alloge-
neic T cells for approximately 2 weeks as detailed in the Methods section. Afterward, the resting differentiated T cells were 
restimulated with PMA/ionomycin and their intracellular IL-4 and IFN-γ levels were analyzed by flow cytometry. E. coli LPS, poly 
I:C and E.coli LPS + PGE2 were used as referencing stimuli for mixed Th1/Th2, Th1 and Th2, respectively. Results (mean and 
SEM) of the T cell responses from 5 different MoDC donors interacting with a same batch of allogeneic T cells are shown as 
per cent of responsive positive T cells in A and a scatter plot from one representative donor is shown in B. Circles indicate the 
predominant Th1 cell population induced by Bp-844 and Bt-UE5.
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line more effectively than Bt-UE5 [6]. In the present study,
we continued this same approach, but this time using pri-
mary human phagocytic cells instead of a non-phagocytic
human and animal cell lines. After internalization, we
found that Bt strain UE5 but not Bp strain 844, had a
reduced survival rate and failed to multiply in the Mφs
(Figure 1A). We have limited data confirming that
another Bp stain (1026b) could also survive and readily
replicate inside primary human macrophages (unpub-
lished). From the current information regarding the differ-
ent characteristics between these 2 Burkholderia species,
we suspect that exopolysaccharide capsular components
[13] or the type-III secretion system cluster 1 [15], which
are absent in Bt, may be responsible for the differences in
their intracellular survival kinetics. Currently, we have
data showing that, compared with its wild type counter-
part, a capsule mutant of Bp that lacks the exopolysaccha-
ride component was at least 105-fold less virulent in
BALB/c mice and it also survived and replicated poorly
inside primary human Mφs (manuscript submitted).
Furthermore, our results showed that following IFN-γ acti-
vation, both MoDCs and Mφs acquired an enhanced abil-
ity to kill Bp-844. The significance of IFN-γ in conferring
resistance against experimental melioidosis has been
reported previously by several groups of investigators
[16,17] including our own group [18]. Unactivated
MoDCs, while possessing an antigen-presenting capacity
for the stimulation of the adaptive immune response that
is superior to that of Mφs, were unable to inhibit the intra-
cellular growth of either Burkholderia strains (Figure 1B).
However, after IFN-γ pre-activation, an enhanced intracel-
lular killing capacity was observed in the MoDCs infected
with Bp-844 (Figure 1D). In vivo, IFN-γ can be produced
by NK cells or Th1 cells [16], but their arrival at the initial
site of infection might be too late to provide an effective
antibacterial response. We previously showed that inject-
ing BALB/c mice with CpG ODN to enhance IFN-γ pro-
duction and innate immunity in general could effectively
protect the animals against a subsequent challenge with
virulent Bp [18]. Furthermore, we found that if the CpG
ODN administration was given closer to the time of bac-
terial challenge, the degree of protection was also reduced.
As demonstrated in the present study, the enhanced in
vitro killing of Bp-844 by human MoDCs and Mφs pre-
stimulated with IFN-γ (Figure 1C) is in accord with the
previously mentioned in vivo observations in experimen-
tal animals. Taken together, it appears that the host innate
immune response is able to distinguish Bp-844 from Bt-
UE5 (Figure 1), and this may in turn influence the out-
come of primary infection by Bp. Once the infection has
progressed beyond this stage, the host adaptive immune
system will be activated but may not be able to distinguish
between these 2 bacteria, as demonstrated by our results
showing the similar patterns of costimulatory molecule
expression, cytokine production and strong bias toward a
Th1 polarization (Figures 2 and 3). In addition, the results
of our in vitro studies showing that human MoDCs that
have been exposed to Bp-844 have predominant biased
effects on Th1 cell differentiation (Figure 3) are consistent
with the results of a previous study showing strong Th1
cell-mediated immune responses in melioidosis patients
who had recovered from melioidosis [11]. Moreover, a
mixed Th1/Th2 response has also been reported in animal
studies [12]. The detection of some activated T cells exhib-
iting a mixed Th1/Th2 response producing both intracel-
lular IFN-γ and IL-4 in this study (Figure 3) is in accord
with the animal study just mentioned. Further investiga-
tions using the human phagocytic cell system described in
the present study are needed if one is to more fully under-
stand the pathogenesis of human melioidosis. We are cur-
rently investigating the possible role and involvement of
polymorphonuclear cells in the disease process in
humans.
Conclusion
Our comparative study showed that while both Bp-844
and Bt-UE5 were similar in their ability to survive and rep-
licate in human MoDCs, only Bp-844 could replicate in
human Mφs. Both bacteria, however, possessed a similar
capacity to stimulate DC maturation, cytokine production
and T cell polarization toward a Th1 phenotype. It is pos-
sible that the superior ability of Bp-844 to survive and rep-
licate in phagocytes may contribute to the virulence of the
organism and thus may influence the outcome of infec-
tion in the human host.
Methods
Bacterial strains
The clinical isolate, Bp strain 844, and the non-pathogenic
environmental isolate, Bt strain UE5, were used in this
study. These strains have been used and more fully char-
acterized in our previous reports [3,6,19]. In brief, Bp-844
is a clinical isolate from a patient admitted to a general
hospital in the endemic Khon Kaen province in Thailand.
It possesses an exopolysaccharide capsular component,
can form biofilms and has a typical LPS phenotype. The
environmental soil isolate, Bt-UE5, while it does not pos-
sess an exopolysaccharide capsule, exhibits a similar LPS
phenotype and biofilm component. Doubling times in a
cell-free system for both strains were calculated and found
to be very similar: 40 min for Bp-844 and 37 min for Bt-
UE5. Late log phase cultures of Bp-844 and Bt-UE5 were
achieved by inoculating them in trypticase soy broth for
16 hr in a rotating incubator. The number of bacteria was
estimated according to the culture's optical density value
at 650 nm and the exact number of colony-forming unit
(cfu) was subsequently determined by serial dilution,
plating on trypticase soy agar and colony counting [3].Page 6 of 8
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driven T helper cell differentiation were prepared by treat-
ing viable bacteria with 1% PFA for 15 min.
Primary human MoDC and Mφ cultures
Blood was collected from healthy adult volunteers who
lived in non-endemic areas for melioidosis in Thailand.
They were considered healthy based on their physical
appearance together with past medical history and were
currently free from any illness and had not taken pharma-
ceutical agents at least one week prior to the time of blood
withdrawal. Ethical clearance for blood collection from
donors was approved by the Ethical Clearance Committee
of Ramathibodi Hospital, Mahidol University, Bangkok,
Thailand (Ethical clearance number 2549/452). Periph-
eral blood mononuclear cells were prepared using Ficoll-
Hypaque separation method [20] and CD14+ monocytes
were isolated using a magnetic cell sorter system as recom-
mended by the manufacturor (MACS®, Miltenyi Biotech
GmbH, Bergisch Gladbach, Germany). Immature MoDCs
were prepared and cultured as described [21] except that
they were cultured in the absence of antibiotics. Briefly,
the purified CD14+ monocytes were cultured for 5–6 days
in 5% CO2, 37°C in RPMI 1640 (Gibco, Grand Island,
NY) supplemented with 10% fetal calf serum (BioWith-
aker, Cambrix, UK), 2 mM L-glutamine, 1% non-essential
amino acids, 1 mM sodium pyruvate and 0.05 mM 2-mer-
captoethanol, in the presence of 100 ng/ml IL-4 and 100
ng/ml GM-CSF (both from R&D Systems, Minneapolis,
MN). The cells generated as such exhibited morphological
and surface characteristics typical of dendritic cells.
Unstimulated Mφs were obtained by culturing the puri-
fied CD14+ monocytes in 10% inactivated human AB
serum (GemCell™, West Sacramento, CA) supplemented
with 1% glutamine in ISCOV's MDM (Gibco) for 5–6
days before used in the experiment [22].
Determination of survival and growth kinetics of bacteria 
inside MoDCs and Mφs
The number of intracellular bacteria was determined using
an antibiotic protection assay [16]. In brief, host cell monol-
ayers were exposed (T0) to viable Bp-844 or Bt-UE5 at a mul-
tiplication of infection of 1 for 2 hr before extracellular
bacteria were eliminated by treating the cells with 250 μg/ml
kanamycin for 1 hr (T3). Thereafter, the cells were cultured in
medium containing 20 μg/ml kanamycin to suppress
growth of any residual viable bacteria that might still be
present. At the time points indicated, the host cells were
lyzed by treating with 0.1% Triton X-100 for 5 min and the
number of intracellular bacteria were counted using stand-
ard plate pouring technique [3]. In the case of IFN-γ pre-stim-
ulation, host cell monolayers were treated with recombinant
human IFN-γ (CytoLab Ltd., Rehovot, Israel) for 16 hr before
the infection was performed. Host cell viability was deter-
mined using 0.04% trypan blue staining to ensure that more
than 90% of the cells remained alive at the final time point.
Determination of surface marker expression and cytokine 
production by infected cells
MoDCs or Mφs were infected with viable Bp-844 or Bt-
UE5 at a MOI of 1 for 2 hr before 250 μg/ml of kanamycin
was added. Twenty-two hr later, supernatants were col-
lected for cytokine assay while infected host cells were dis-
lodged for determining the surface expression of CD40,
CD80, CD83, CD86 and CD11b upon incubation with
fluorescently-labelled antibodies (BD Biosciences, San
Jose, CA) and analyzed by flow cytometry (FACSCanto,
BD Biosciences) as described [7,9,21]. Levels of cytokines
in supernatants were measured using commercial ELISA
kits: IL-12p70 and IL-10 (both from BD Biosciences) and
TNF-α (R&D Systems).
Determination of DC-driven Th1-Th2 differentiation
MoDCs were stimulated for 24 hr with PFA-fixed Bp-844
or Bt-UE5 at a MOI of 1 and their ability to induce alloge-
neic T cell differentiation was determined [9]. In brief, Bp-
844- or Bt-UE5-activated MoDCs were co-cultured with
allogeneic CD45RA+CD4+T cells at a ratio of 5,000
MoDCs per 20,000 T cells for 12–14 days in the presence
of 100 iU/ml IL-2 (R&D Systems) from day 5 onwards.
Differentiated T cells were then restimulated with 10 ng/
ml PMA and 1 μg/ml inonomycin (both from Sigma-
Aldrich, St. Louis, MO) for 6 hr. Intracellular IFN-γ and IL-
4 production were measured by flow cytometry on a sin-
gle cell basis and the type of T cell differentiation was
determined based on the ratio of IFN-γ and IL-4 produc-
ing cells. Each set of experiments always included control
agents referencing for different T cell polarization, i.e., 5
μg/ml E. coli LPS (Sigma-Aldrich) for mixed Th1/Th2, 100
μg/ml poly I:C (Invitrogen, Carlsbad, CA) for Th1 and 5
μg/ml E. coli LPS plus 10 μg/ml prostagrandin E2 (PGE2,
Invitrogen) for Th2 [9].
Statistical analysis
Differences between 2 groups were analyzed using paired-
samples t-test and differences among multiple groups
were analyzed using the one-way ANOVA test. P-values of
< 0.05 were considered statistically significant.
Abbreviations
Bp: Burkholderia pseudomallei; Bt: Burkholderia thailandensis;
Mφs: macrophages; MoDCs: monocyte-derived dendritic
cells; PFA: paraformaldehyde; LPS: lipopolysaccharide;
PBS: phosphate buffered saline pH 7.4; PGE2: prostagran-
din E2; cfu: colony-forming unit; MOI: multiplicity of
infection.
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